Open AccessMulti-center clinical study of Parkon® efficiency
Author(s) -
N V Fjodorova,
V.N. Shtok,
Gusev Ei,
G Naum
Publication year - 2021
Publication title -
open journal of parkinson s disease and treatment
Language(s) - English
Resource type - Journals
ISSN - 2692-4617
DOI - 10.17352/ojpdt.000011
Subject(s) - parkinsonism , hydrogen peroxide , medicine , active ingredient , disease , pharmacology , chemistry , organic chemistry
The purpose of the study was to investigate the efficacy of Parkon® spray as the compound for the effect on motor disturbances in treatment of both Parkinson’s Disease (PD) and neuroleptic-induced Parkinsonism. The main active ingredient of Parkon® is low concentrated hydrogen peroxide [1-3].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom